Ottawa prepares for future pandemics with launch of life science strategy, CellCAN and CCRM launch a new cell and gene therapy institute to tackle gaps in training, a new fund dedicated to developing transit solutions for rural and remote communities, and more.
Organization: Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac)
The Short Report – Sept. 30, 2020: CARIC wraps up operations, U of T receives its largest donation yet, and more
The University of Toronto Faculty of Medicine will benefit from a $250 million donation to support advances in human health and health care; Roger Scott-Douglas is the acting new president of the National Research Council of Canada.
VIDO-InterVac in Saskatchewan fielding massive demand for testing of COVID-19 vaccines and therapeutics
One of the largest “containment Level 3” facilities in the world, University of Saskatchewan’s Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac) in Saskatoon is receiving daily requests from researchers, companies and governments to test COVID-19 vaccines and therapies.
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...